A Bet on Magic Mushrooms Made One Investor $316 Million Richer
- Christian Angermayer holds 22% stake in Compass Pathways
- German investor’s ATAI Life Sciences may go public in 2021
This article is for subscribers only.
Christian Angermayer spent years convincing skeptical investors of the promise in psychedelic substances to treat mental illness. His efforts paid off this week to the tune of $316 million.
That’s how much the 42-year-old’s stake of about 22% in Compass Pathway Plc’s is worth, after the company’s shares more than doubled in the days following its Sept. 18 initial public offering.